TC
WST icon

Toews Corporation’s West Pharmaceutical WST Stock Holding History

Toews Corporation’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,400
Closed -$958K – 117
2021
Q1 		$958K Buy
+3,400
New +$973K 0.08% 32
2020
Q4 		– Sell
-3,600
Closed -$990K – 115
2020
Q3 		$990K Buy
+3,600
New +$953K 0.3% 60

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Toews Corporation's WST Position: Q2 2021 in Review

Toews Corporation sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 3,400 shares — an estimated $958K sold.

Toews Corporation first reported a position in WST in Q3 2020 and held it in 2 quarters. The position peaked at $990K in Q3 2020. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • Toews Corporation reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • Toews Corporation sold 3,400 West Pharmaceutical shares in Q2 2021, an estimated $958K.
  • Toews Corporation first reported a position in West Pharmaceutical in Q3 2020 and held it in 2 quarters.
  • Toews Corporation's West Pharmaceutical position peaked at $990K in Q3 2020.
  • 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on Toews Corporation's 13F filing for Q2 2021, filed 2 Aug 2021.